Literature DB >> 9473092

Infant pediatric liver transplantation results equal those for older pediatric patients.

W J Van der Werf1, A M D'Alessandro, S J Knechtle, G Pilli, R M Hoffmann, R H Judd, J S Odorico, A D Kirk, S C Rayhill, H W Sollinger, M Kalayoglu.   

Abstract

METHODS: From July 1984 to July 1995, 99 pediatric patients underwent 127 orthotopic liver transplants (OLT) at the University of Wisconsin Children's Hospital. The patients were divided into four groups according to age at time of transplant: group I, 0 to 6 months (n = 20); group II, 6 to 12 months (n = 18); group III, 1 to 2 years (n = 10); and group IV, 2 to 18 years (n = 51). A retrospective analysis was performed to compare these four groups with regard to preoperative indications and demographics, intraoperative technique, complications, and survival. All patients were followed up for 2 to 13 years.
RESULTS: Biliary atresia was the most common indication for OLT in all four groups. The average waiting period varied from 19+/-18 days for group I to 44+/-64 days for group IV. Reduced-size liver transplant (I, 41%; II, 52%; III, 28%; IV, 21%), split-liver transplant (I, 0%; II, 7.4%; III, 17%; IV, 2.9%), or whole-liver transplant techniques were used. Although postoperative Intensive Care Unit stay was longer for the 0- to 6-month-old patients (I, 20+/-64; II, 7.6+/-9; III, 13+/-17; IV, 6.8+/-14 days), the total hospital stay (I, 43+/-63; II, 33+/-34; III, 32+/-20; IV, 29+/-31 days) was similar for all patients. The incidence of hepatic artery thrombosis (I, 19%; II, 19%; III, 27%; IV, 16%), biliary tract complications (I, 4.8%; II, 15%; III, 20%; IV, 14%), and retransplantation (I, 9.5%; II, 41%; III, 33%; IV, 14%) were not significantly different between the four groups. Portal vein thrombosis (I, 9.5%; II, 11%; III, 6.6; IV, 0%) and primary nonfunction (I, 9.5%; II, 7.4%; III, 0%; IV, 3.1%) occurred more frequently in the 0- to 6-month and 6- to 12-month groups, however, the 1-, 5-, and 10-year survival rate for patients (I, 85%, 79%, 79%; II, 89%, 74%, 74%; III, 80%, 80%, 80%; IV, 84%, 75%, 75%, respectively) and primary liver allografts (I, 69%, 69%, 69%; II, 72%, 72%, 63%; III, 70%, 70%, 70%; IV, 71%, 57%, 57%, respectively) were not significantly different (P = .98 and P = .83).
CONCLUSION: These results demonstrate that OLT can be effectively performed on infants of all ages and that OLT should not be delayed because of age.

Entities:  

Mesh:

Year:  1998        PMID: 9473092     DOI: 10.1016/s0022-3468(98)90353-0

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases.

Authors:  Robert S Venick; Douglas G Farmer; Sue V McDiarmid; John P Duffy; Sherilyn A Gordon; Hasan Yersiz; Johnny C Hong; Jorge H Vargas; Marvin E Ament; Ronald W Busuttil
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

2.  Pediatric liver transplantation. A single center experience spanning 20 years.

Authors:  Ashok Jain; George Mazariegos; Randeep Kashyap; Beverly Kosmach-Park; T E Starzl; John Fung; Jorge Reyes
Journal:  Transplantation       Date:  2002-03-27       Impact factor: 4.939

3.  Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients.

Authors:  J M Millis; D C Cronin; L M Brady; K A Newell; E S Woodle; D S Bruce; J R Thistlethwaite; C E Broelsch
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

4.  Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program.

Authors:  Paul R Atkison; B Catherine Ross; Sandy Williams; John Howard; John Sommerauer; Douglas Quan; William Wall
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

5.  Long term outcomes of pediatric liver transplantation according to age.

Authors:  Jeik Byun; Nam-Joon Yi; Jeong-Moo Lee; Suk-won Suh; Tae Yoo; YoungRok Choi; Jae-Sung Ko; Jeong-Kee Seo; Hyeyoung Kim; Hae Won Lee; Hyun-Young Kim; Kwang-Woong Lee; Sung-Eun Jung; Seong-Cheol Lee; Kwi-Won Park; Kyung-Suk Suh
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.